Norgestrel is a synthetic progestin that is a key ingredient in many hormonal contraceptives. It is a derivative of the hormone progesterone, has similar activity and activity in pregnant women. It is widely used as a safe and effective method of birth control that gives women control over their birth.
Norgestrel was first developed in the early 1960s and has been meticulously researched and optimized for its anti-inflammatory properties while minimizing side effects. It is often found in combined oral contraceptives with ethinyl estradiol, an estrogen.
This combination is effective against pregnancy by reducing ovulation, thickening the cervical mucus to prevent sperm, and altering the lining of the uterus to prevent implantation. The wide availability of Norgestrel makes it a popular choice for women seeking reliable and reversible birth control options. Also, its use is not limited to the prevention of diseases; Norgestrel is also used to treat certain gynaecological diseases and hormonal imbalances.
As with any medication, it is important to understand the benefits, risks, and proper use of Norgestrel. For people considering taking birth control pills, it is important to consult a doctor to determine the most appropriate method of contraception based on their medical history and lifestyle.
In this article, we will talk about norgestrel’s pharmacology, mechanism of action, various formulations, possible side effects, and other important factors to better understand this important hormonal contraceptive and its role in female development.
Mechanism of Action
Norgestrel, as a synthetic progestin, exerts its contraceptive effect mainly by interacting with progesterone receptors in the female reproductive system. Norgestrel’s mechanism of action consists of several important mechanisms that work together to prevent pregnancy. Here is a detailed explanation of its mechanism:
Inhibits ovulation: One of the main functions of Norgestrel is to inhibit ovulation, which is the release of a large egg from the ovary. Normally, during pregnancy, the pituitary gland in the brain secretes luteinizing hormone (LH) and follicle stimulating hormone (FSH), which stimulate the ovaries to produce estrogen and progesterone. These hormones also stimulate the development and release of the mature egg.
Norgestrel is a progestin that inhibits the production of LH from the pituitary gland, thereby preventing the LH surge that leads to ovulation. Without the LH surge, the mature egg is not released, making fertilization and getting pregnant impossible.
Thickening of cervical mucus: Norgestrel changes the quality of cervical mucus, making it thicker and more viscous. This change in the cervix makes it difficult for sperm to swim across the cervix and reach the fallopian tubes, where fertilization usually occurs. Thick mucus causes congestion, inhibits sperm movement and reduces the chances of successful fertilization.
Changes in the uterine wall: Norgestrel can cause changes in the lining of the uterus. Usually during pregnancy, the lining of the uterus thickens in preparation for potential embryo implantation. However, under the influence of norgesrel, the lining of the uterus thins, making it difficult for embryos to implant. This makes it less likely for a fertilized egg to implant in the lining of the uterus and become pregnant.
Inhibits peristalsis of the fallopian tubes: Norgestrel can also reduce the peristalsis or movement of the tubes that carry the eggs from the ovaries to the uterus.Norgestrel slows the movement of blood vessels through the blood vessels, reducing the chance for the egg to meet and fertilize the sperm.
It is important to remember that the effectiveness of norgestrel as a contraceptive method depends on correct and correct use. Taking or using it regularly can reduce its effectiveness and increase the risk of unwanted pregnancy. Therefore, people using norgestrel contraceptives should follow the prescribed regimen and follow the instructions given by the doctor.
Diagrammatic Representation of Opill Action
Clinical Trials History
| Adverse Reactions Reported with POPs | Adverse Reactions Reported in Clinical Studies |
| – Delayed follicular atresia/ovarian cysts | – Headache |
| – Menstrual irregularity, changes in menstrual flow | – Dizziness |
| – Breakthrough bleeding/spotting | – Nausea |
| – Amenorrhea | – Increased appetite |
| – Prolonged bleeding | – Abdominal pain, cramps, and bloating |
| – Fatigue | |
| – Vaginal discharge | |
| – Dysmenorrhea | |
| – Nervousness | |
| – Backache | |
| – Breast discomfort |
In addition, clinical studies have shown that spontaneous bleeding and bleeding are the most common side effects and are the main reason for discontinuation of the drug. About half of the subjects experienced some menstrual changes. During the reporting period, bleeding occurred in 11.8%, spotting in 12.2%, and amenorrhea in 6 patients.1% of studies in the first cycle and 28.7% of studies in the study period. Menstrual bleeding lasted longer than 8 days in 8.5% of reported cases. A total of 379 participants (17.4% discontinued treatment due to side effects, of which 68% discontinued treatment due to menstruation. Overall, 6.4% of the participants discontinued treatment due to bleeding and 2.7% discontinued treatment due to amenorrhea. It is important to note thatNorgestrel and levonorgestrel are similar compounds whose safety has been extensively evaluated through post-marketing studies and published data. Most of the evidence shows that the use of progestin-only pills, including norgestrel, does not increase the risk of thromboembolic events. Reported side effects are based on the well-known safety of this drug.
Advantages of Norgestrel
A synthetic progestin and the main ingredient in many hormonal contraceptives, Norgestrel has many benefits that make it a popular choice for women looking for an effective and reversible birth control option. Some of the main benefits of Norgestrel are:
Excellent protection: Norgestrel is a reliable birth control method when used correctly. Taken regularly as directed, it has a high level of protection against pregnancy, making it an attractive choice for women wishing to become pregnant.
Reversible contraceptive options: Unlike permanent contraceptives such as sterilization, Norgestrel contraceptives have the advantage of being reversible. When a woman stops taking norgestrel, her fertility usually returns to normal quickly, allowing her to plan future pregnancies as needed.
Ease of use: Norgestrel is usually given as a convenient and easy-to-use oral contraceptive. Taking birth control pills at the same time each day is an easy and safe way to make sure your birth control is working.
Regulating menses: Norgestrel-based contraceptives can help regulate menstruation and reduce symptoms associated with irregular or heavy menstrual periods. Some women may have easier, more predictable periods while on the pill.
Reduces Herpes: For women with herpes, norgestrel can help reduce discomfort by reducing the intensity of menstrual uterine contractions.
Treatment of gynecological diseases: Norgestrel is used to treat certain gynecological diseases such as endometriosis and polycystic ovary syndrome (PCOS) by inhibiting abnormal tissue growth and regulating hormone levels.
Reduces the risk of certain cancers: Studies show that the use of birth control pills containing norgestrel may be associated with a reduced risk of ovarian and endometrial cancers.
Improvement in acne control: Some women have experienced improvement in acne symptoms when using norgestrel oral contraceptives because these pills contain anti-inflammatory substances that reduce excessive sebum production.
Does not interfere with sexual spontaneity: Unlike problematic procedures or intrauterine devices (IUDs), which must be done just before intercourse, oral contraceptives can cause sexual spontaneity because they are taken every day and do not require additional preparation. It is important to remember that while
Norgestrel contraceptives have many advantages, they may not be suitable for everyone. Women with certain medical conditions or health conditions should consult their healthcare provider to determine the best contraceptive option for their needs and condition.
Disadvantages of Norgestrel
While Norgestrel-based birth control pills have many advantages, they also have some disadvantages and side effects. These factors should be considered when choosing a prevention method. Some of the negative side effects of Norgestrel are:Menstrual Irregularity: Some women may experience menstrual irregularities while using birth control pills containing norgestrel. This may include irregular bleeding, menstrual bleeding, or changes in the timing and intensity of menstrual bleeding.
Hormonal side effects: As with all hormonal contraceptives, norgestrel can cause side effects due to hormonal fluctuations.These side effects can include breast tenderness, mood changes, headaches and nausea. Although these symptoms are usually mild and temporary, they can affect some women.
Missed doses and reduced efficacy: For oral contraceptives to be most effective, they must be taken regularly at the same time each day. Not taking the pill or taking it regularly can make it ineffective in preventing pregnancy.Does not protect against sexually transmitted infections: Birth control pills containing norgestrel do not protect against sexually transmitted infections (STIs).Therefore, if protection against sexually transmitted infections is required, a barrier method (such as a condom) should be used in addition to hormonal protection.
Potential health risks: While Norgestrel, like all hormonal contraceptives, is generally considered safe for most women, it carries a small risk for certain conditions. These can include an increased risk of blood clots, heart problems, and in some cases, high blood pressure. Women who smoke, are elderly, or have certain pre-existing medical conditions are generally at higher risk.
Not suitable for certain conditions: Birth control pills containing norgestrel may not be suitable for women with certain conditions, such as blood clots, liver disease, or certain types of cancer.It is important to discuss any existing medical conditions with your doctor before starting the birth control pill norgestrel.
Interactions with other medications: Norgestrel can interact with some medications, including some antibiotics and contraceptives, making your birth control worse. The doctor should be informed about all medications taken to prevent side effects.
Not suitable for all women: While Norgestrel birth control pills are suitable for many women, some women may not tolerate good hormonal birth control pills or prefer non-hormonal birth control pills.
As with all medications, the benefits and risks of norgestrel contraceptives should be carefully evaluated and individuals should discuss contraceptive options with their physician to determine the most appropriate method based on their health needs and preferences.
Market Key Insights
The global immunotherapy market was valued at US$22.49 billion in 2019 and is expected to grow by 30.15.5% over the forecast period. Birth control is voluntary control of pregnancy through the use of contraceptives or equipment and surgical procedures such as making women independent of the method of contraception.
There are many effective ways to reduce premature death. According to the World Health Organization (WHO), in 2016, of the 214 million countries that wanted to avoid pregnancy, the countries with the least knowledge of modern contraception methods. However, promoting women’s health and well-being through a variety of home economics awareness campaigns and programs is important work to do. The most important thing is to do business.
Forecast of Contraceptive Market
The global birth control pills market is valued at $28.3 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.06% from 2020 to 2030. According to the World Health Organization data, There are 9 billion women of reproductive age (15-49 years) worldwide in 2019, of whom about 1.1 billion need family planning.
Of these, about 842 million women use contraception for family planning, and about 270 million women have unwanted contraception.
Contraceptive Market
Implementation of programs aimed at reducing unwanted pregnancies and associated medical costs, along with user awareness level, is expected to drive market growth during the forecast period. In addition, the increase in the number of unwanted pregnancies will support the growth of the market during the forecast period.
According to The Lancet Global Health, an average of approximately 121 million 4,444 unplanned pregnancies occurred worldwide between 2015 and 2019, or approximately 64 unplanned pregnancies per 1,000 4,444 women of reproductive age.
Family Planning
For example, Family Planning 2020, an initiative launched in 2012 and continuing through 2020, provides international collaboration to share informationand provide legal, people-based policies for family planning.
The plan has been expanded by 2030 to provide global access to 4,444 birth control methods and other family planning. Both private companies (pharmacies/dispensaries, grocers/stores, private clinics, and NGOs or religious organizations) and the public are major suppliers of vaccines worldwide.
Pictorial Representation in US market
COVID-19 Contraceptive Market Impact: 5.60% increase from 2020 to 2021
| Pandemic Impact | Post COVID Outlook |
| The COVID-19 pandemic negatively impacted the industry owing to the disruption of reproductive & sexual health services due to the contraceptive supply chain halts. As per the research article published in Relias Media, a decline of 46% was reported for long-active contraceptive usage in the U.S. in 2020 | The demand for condoms & pills increased from the second half of 2020 to the first half of 2021 in the U.S. toward the end of 2021, the demand for condoms reduced to pre-pandemic levels as ease in restrictions and vaccination drives improved access to the prescribed methods of contraception. |
| Access to contraceptives declined during the pandemic owing to guidelines associated with the use of contraceptives hampering the vaccine efficacy and side effects, such as blood clotting associated with it. For instance, in April 2021, the Central Epidemic Command Center (CECC) of Taiwan Centers for Disease Control announced to take precautions before vaccinating with the AstraZeneca vaccine. The reminder notice was circulated, which states undergoing hormone therapy and taking contraceptive pills could lead to a risk for blood clotting, and was advised to stop taking these treatments before 28 days of vaccination. | The adoption of telehealth is expected to propel the demand for contraceptives post-pandemic. Many service providers are broadening access via telehealth and are offering contraception consulting |
According to a 2022 article in the Journal of Global Health: Research and Practice, about 41 percent of women using contraception in Asia get their vaccines from the private sector, and about 56 percent from public sources. In the overall average of the 36 low- and middle-income countries (LMICs) surveyed, about 63 percent of women received information from private sources and about 34 percent used public resources. The government has done a lot of advertising and sex education to raise awareness among young people and to promote the use of birth control pills to prevent STDs and unwanted pregnancies. International health organizations and governments, such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), play an important role in promoting awareness of safe sex with condoms.
Contraceptive Product Market Insights
On a product basis, the global market is segmented into anti-inflammatory drugs and anti-inflammatory products. Antibiotic products dominate the market with the largest revenue share of more than 65.66% in 2022 and is expected to record the highest growth rate over the forecast period with a CAGR of 7.12%. This is due to increased awareness of STDs and the increasing effectiveness of condoms against infections, including HIV.
In a recent study, it was shown that subcutaneous implants are effective in family planning of women. Birth control devices are classified as condoms, implants, IUDs, vaginal rings and diaphragms.
Condoms will have the largest share in 2021 due to increased demand in Europe and Asia Pacific. This growth can also be attributed to demand from the public sector. According to the 2021 Family Planning Report, the Ministry of Health and Family Welfare of India provided 378.1 million condoms. Contraceptives should show good growth over the forecast period. This continues with vaccines, patches, and vaccines. In 2021, the contraceptives segment had the largest share of the segment.
This increase is due to the purchase of goods by public institutions. Commercial packaging of birth control pills, including combined birth control pills and progestogen-only birth control pills, accounted for approximately 201 million pills in the FP2020 commercial packaging, according to the Clinton Health Promotion Program’s 2021 Planned Parenthood report. These pills are cheaper than birth control pills.According to an article published in The Lancet, about 14.8% of infections in 2019 are attributed to antibiotics.
Global Market Size
Regional Insights
North America region will lead the global market with the largest revenue of more than 32.90% in 2021 and is expected to maintain its position throughout the forecast period due to the high number of abortions, increasing number of women aged 15-44 and high patient awareness in the region. The introduction of widely available and low-cost drugs and materials has also increased the demand for anti- pregnancy drugs among young people. In April 2022, Reckitt Benckiser launched a new type of condom: Durex Intense. Asia Pacific is expected to witness the fastest CAGR during the forecast period.
This growth can be attributed to increased government programs, increased demand for population control, and a reduction in unwanted pregnancies. According to the World Health Organization, about 53.8 million unintended pregnancies occur each year in Asia, of which about 65 percent are abortions. The prevalence of sexually transmitted diseases among young married couples in Asia is approximately 41%. Europe has a significant market share in 2021 due to the potential payback for the use of contraceptive drugs.
According to the European Union Center for Reproductive Rights’ Access to Birth Control report, in Germany IUDs, emergency contraception and hormonal contraceptives are covered by the compulsory health insurance scheme for women under 18. Women aged 18-19 pay a 10% out-of-pocket fee of €10 per document. This program covers birth control pills used by women aged 20 and over for reasons other than birth control.
Key Market Players
June 2021 – Emme, a health tech company, has launched a birth control tracking smart data and app that now offers delivery and phone services. The new link, called EmmeRx, means patients in 16 states can give birth.
April 2021 – Mayne Pharma receives US FDA approval for NEXTSTELLIS (3 mg of drospirenone [DRSP] and 14.2 for birth control).
March 2021 – The guide provides users with a digital birth control method that provides ovulation prediction at birth. May 2020 – Evofem Biosciences Inc.
Phexxi, the first non-hormonal birth control method, has been approved by the FDA.
Conclusion
Researching the vaccine business reveals some great insights into the current state of the vaccine industry and the vaccine industry. Here are some key usage points:
Use of birth control pills: According to a United Nations report, 45.2% of people who use birth control pills rely on long-acting or long-acting methods such as male and female sterilization, IUD, and implants, while 46.1% use it. short-term methods such as oral contraceptives and condoms.Market Size: Global Antibiotic market value is USD 16.It will reach $44 billion in 2022 and is expected to reach $28.03 billion in 2030 with a CAGR of 5.32%. In the United States, contraceptives are divided into pills, IUDs, condoms, vaginal rings, subcutaneous implants, injections, and more.
Competition: The vaccine market is highly competitive with many options available to consumers.Oral contraceptives are the most widely used birth control method in the world and the market is large and mature. But other methods such as the IUD and subcutaneous implant are gaining popularity because of their good results and long-term results.
Birth control: Although there are many forms of birth control, many prevent women from using or regularly using contraceptives. These barriers include cost, lack of insurance coverage, and limited access to healthcare.Patient preference: Patient selection and efficacy should be important in choosing an immunosuppressive regimen.A report by the Kaiser Family Foundation found that oral contraceptives (14%), female sterilization (14%), and condoms (11%) were the most commonly used birth control methods among women aged 15-49 in the United States.
In summary, research on the vaccine industry shows that the vaccine market is competitive and consumers have a variety of vaccines to choose from. Patient preference and efficacy should be important factors in immunotherapy selection. However, many issues highlight the need to improve health and insurance coverage by preventing women from accessing or using birth control methods effectively and regularly.
References
- Improving Contraceptive Use and Acceptability – NCBI [Link: https://www.ncbi.nlm.nih.gov/books/NBK215970/]
- Contraceptive Technology and the State of the Science: Current and Near-future Methods [Link: https://www.ncbi.nlm.nih.gov/books/NBK232749/]
- India’s family planning market and opportunities for the private sector: An analysis using the total market approach – Wiley Online Library [Link: https://onlinelibrary.wiley.com/doi/full/10.1002/hpm.2753]
- U.S. Contraceptive Market Size & Share Report, 2030 [Link: https://www.grandviewresearch.com/industry-analysis/us-contraceptive-market]
- Contraception – References | BMJ Best Practice US [Link: https://bestpractice.bmj.com/topics/en-us/418/references]
- A Huge Marketing Research Task: Birth Control – JSTOR [Link: https://www.jstor.org/stable/3149789]
Leave a Reply